POINTS OF INTEREST

Global burden of cancers attributable to infections in 2008:
a review and synthetic analysis

Catherine de Martel MD, Jacques Ferlay ME, Silvia Franceschi MD, Jérôme Vignat MSc, Freddie Bray PhD, David Forman PhD, Dr Martyn Plummer PhD

Summary

Background

Infections with certain viruses, bacteria, and parasites have been identified as strong risk factors for specific cancers. An update of their respective contribution to the global burden of cancer is warranted.

Methods

We considered infectious agents classified as carcinogenic to humans by the International Agency for Research on Cancer. We calculated their population attributable fraction worldwide and in eight geographical regions, using statistics on estimated cancer incidence in 2008. When associations were very strong, calculations were based on the prevalence of infection in cancer cases rather than in the general population. Estimates of infection prevalence and relative risk were extracted from published data.

Findings

Of the 12·7 million new cancer cases that occurred in 2008, the population attributable fraction (PAF) for infectious agents was 16·1%, meaning that around 2 million new cancer cases were attributable to infections. This fraction was higher in less developed countries (22·9%) than in more developed countries (7·4%), and varied from 3·3% in Australia and New Zealand to 32·7% in sub-Saharan Africa. Helicobacter pylori, hepatitis B and C viruses, and human papillomaviruses were responsible for 1·9 million cases, mainly gastric, liver, and cervix uteri cancers. In women, cervix uteri cancer accounted for about half of the infection-related burden of cancer; in men, liver and gastric cancers accounted for more than 80%. Around 30% of infection-attributable cases occur in people younger than 50 years.

Interpretation

Around 2 million cancer cases each year are caused by infectious agents. Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide.

Funding

Fondation Innovations en Infectiologie (FINOVI) and the Bill & Melinda Gates Foundation (BMGF).

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(12)70137-7/fulltext

An Summarized Report for Members
From THE BRIDGE Newsletter of OIRF
Published Octobewr 2012

The Lancet Oncology
Volume 13, Issue 6, Pages 607-615, June 2012
Doi: 10.1016/S1470-2045(12)70137
Published online: 09 May 2012

This study summary was mentioned in the Naturheilpraxis journal under the heading “Every Sixth Cancer Case Worldwide is Caused by Infections”!!
Naturheilpraxis mit Naturmedizin, Vol. 65, June 2012

Featured News

  • Hops and Cocoa

    Hops and Cocoa Against Cancer and Allergies Targeted Help with Orthomolecular Therapy Orthomolecular cancer therapy gains greater and greater insights [...]

    June 15, 2010|Journal Translations|
  • Practice Application – Ondamed

    The applied methodology with the ONDAMED System is founded on the basis of respect and honor for each individual life and the individual truth [...]

    May 15, 2017|Articles|
  • Water Before Bedtime

    POINTS OF INTEREST Submitted by Dr. Sir Zenon Gruba: Water Before Bedtime [Zenon’s note: I don’t know if this works – but it’s worth [...]

    April 15, 2012|Points of Interest|
  • The Crisis

    The Crisis in Biological Medicine in North America Over the past few years we have witnessed the continuing losses of the men and women [...]

    October 15, 2012|Commentaries & Editorials|

Sign-up to receive updates sent straight to your inbox